Preliminary psychometric validation of patient-reported outcomes relevant to individuals with spinal muscular atrophy and their caregivers

Abstract Background There is a need to expand the current scope of assessment tools usually applied to patients with Spinal Muscular Atrophy (SMA). This study aimed to assess the psychometric properties (reliability and discriminant validity) of a set of new patient-reported outcome measures (PROMs)...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Grazia Cattinari, Samuel Ignacio Pascual-Pascual, Mencía de Lemus, Julita Medina, María Dumont, Pablo Rebollo, Juan Francisco Vázquez-Costa
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-025-03832-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849434326348857344
author Maria Grazia Cattinari
Samuel Ignacio Pascual-Pascual
Mencía de Lemus
Julita Medina
María Dumont
Pablo Rebollo
Juan Francisco Vázquez-Costa
author_facet Maria Grazia Cattinari
Samuel Ignacio Pascual-Pascual
Mencía de Lemus
Julita Medina
María Dumont
Pablo Rebollo
Juan Francisco Vázquez-Costa
author_sort Maria Grazia Cattinari
collection DOAJ
description Abstract Background There is a need to expand the current scope of assessment tools usually applied to patients with Spinal Muscular Atrophy (SMA). This study aimed to assess the psychometric properties (reliability and discriminant validity) of a set of new patient-reported outcome measures (PROMs) called PROfuture, after analysing the performance of individual items of the questionnaires. Results Patients included in the Spanish SMA Patient-Reported Registry (RegistrAME) were invited to answer 10 questionnaires: Fatigability; Pain; Scoliosis and Contractures (S&C); Feeding (F); Breathing and Voice (B&V); Sleep and Rest (S&R); Vulnerability; Infections and Hospitalisations (I&H); Time spent in care (T); and Mobility and Independence (M&I). The diagnosis date, type of SMA, functional classification, and comorbidities were also collected. A total of 160 patients of the 330 included in RegistrAME participated in the study: mean age (SD) 18 (16.6) years, 27.5% non-sitter, 46.88% sitter, and 25.63% walker, 20.0% type 1 SMA, 51.88% type 2, and 28.12% type 3. The frequency of symptoms varied from 43.5% of patients reporting some degree of Pain to 96.3% reporting some degree of Fatigability. The reliability assessed by Cronbach’s alpha coefficient was > 0.75 for all the PROs and > 0.9 for S&C, F, B&V, T, and M&I. Regarding content validity, scores were higher (worse health status) in type 1 SMA patients than in types 2 and 3, and were also higher for non-sitter patients than for sitter and walker patients. Conclusions The ten questionnaires included in the PROfuture set were developed based on what people living with spinal muscular atrophy and their caregivers consider relevant. This preliminary study provides an initial basis to consider their potential usefulness in assessing aspects that matter to this population. The early findings are promising, however, further extensive psychometric evaluation is needed. PROfuture is a new set of patient-reported outcome measures, specifically designed by and for individuals living with spinal muscular atrophy and their caregivers. Future studies will help strengthen the evidence regarding its reliability and validity.
format Article
id doaj-art-18dbf21b22df4c34965c162add2ae0ba
institution Kabale University
issn 1750-1172
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj-art-18dbf21b22df4c34965c162add2ae0ba2025-08-20T03:26:43ZengBMCOrphanet Journal of Rare Diseases1750-11722025-06-0120111010.1186/s13023-025-03832-yPreliminary psychometric validation of patient-reported outcomes relevant to individuals with spinal muscular atrophy and their caregiversMaria Grazia Cattinari0Samuel Ignacio Pascual-Pascual1Mencía de Lemus2Julita Medina3María Dumont4Pablo Rebollo5Juan Francisco Vázquez-Costa6Fundacion Atrofia Muscular Espinal España (FundAME)Hospital Universitario La Paz, Universidad Autónoma de MadridFundacion Atrofia Muscular Espinal España (FundAME)Hospital Sant Joan de Deu, Institut de Recerca San Joan de DeuFundacion Atrofia Muscular Espinal España (FundAME)IqviaHospital Universitario y PolitécnicoAbstract Background There is a need to expand the current scope of assessment tools usually applied to patients with Spinal Muscular Atrophy (SMA). This study aimed to assess the psychometric properties (reliability and discriminant validity) of a set of new patient-reported outcome measures (PROMs) called PROfuture, after analysing the performance of individual items of the questionnaires. Results Patients included in the Spanish SMA Patient-Reported Registry (RegistrAME) were invited to answer 10 questionnaires: Fatigability; Pain; Scoliosis and Contractures (S&C); Feeding (F); Breathing and Voice (B&V); Sleep and Rest (S&R); Vulnerability; Infections and Hospitalisations (I&H); Time spent in care (T); and Mobility and Independence (M&I). The diagnosis date, type of SMA, functional classification, and comorbidities were also collected. A total of 160 patients of the 330 included in RegistrAME participated in the study: mean age (SD) 18 (16.6) years, 27.5% non-sitter, 46.88% sitter, and 25.63% walker, 20.0% type 1 SMA, 51.88% type 2, and 28.12% type 3. The frequency of symptoms varied from 43.5% of patients reporting some degree of Pain to 96.3% reporting some degree of Fatigability. The reliability assessed by Cronbach’s alpha coefficient was > 0.75 for all the PROs and > 0.9 for S&C, F, B&V, T, and M&I. Regarding content validity, scores were higher (worse health status) in type 1 SMA patients than in types 2 and 3, and were also higher for non-sitter patients than for sitter and walker patients. Conclusions The ten questionnaires included in the PROfuture set were developed based on what people living with spinal muscular atrophy and their caregivers consider relevant. This preliminary study provides an initial basis to consider their potential usefulness in assessing aspects that matter to this population. The early findings are promising, however, further extensive psychometric evaluation is needed. PROfuture is a new set of patient-reported outcome measures, specifically designed by and for individuals living with spinal muscular atrophy and their caregivers. Future studies will help strengthen the evidence regarding its reliability and validity.https://doi.org/10.1186/s13023-025-03832-ySpinal muscular atrophyPatient reported outcomesPsychometric propertiesQuality of lifeTreatment outcomes
spellingShingle Maria Grazia Cattinari
Samuel Ignacio Pascual-Pascual
Mencía de Lemus
Julita Medina
María Dumont
Pablo Rebollo
Juan Francisco Vázquez-Costa
Preliminary psychometric validation of patient-reported outcomes relevant to individuals with spinal muscular atrophy and their caregivers
Orphanet Journal of Rare Diseases
Spinal muscular atrophy
Patient reported outcomes
Psychometric properties
Quality of life
Treatment outcomes
title Preliminary psychometric validation of patient-reported outcomes relevant to individuals with spinal muscular atrophy and their caregivers
title_full Preliminary psychometric validation of patient-reported outcomes relevant to individuals with spinal muscular atrophy and their caregivers
title_fullStr Preliminary psychometric validation of patient-reported outcomes relevant to individuals with spinal muscular atrophy and their caregivers
title_full_unstemmed Preliminary psychometric validation of patient-reported outcomes relevant to individuals with spinal muscular atrophy and their caregivers
title_short Preliminary psychometric validation of patient-reported outcomes relevant to individuals with spinal muscular atrophy and their caregivers
title_sort preliminary psychometric validation of patient reported outcomes relevant to individuals with spinal muscular atrophy and their caregivers
topic Spinal muscular atrophy
Patient reported outcomes
Psychometric properties
Quality of life
Treatment outcomes
url https://doi.org/10.1186/s13023-025-03832-y
work_keys_str_mv AT mariagraziacattinari preliminarypsychometricvalidationofpatientreportedoutcomesrelevanttoindividualswithspinalmuscularatrophyandtheircaregivers
AT samuelignaciopascualpascual preliminarypsychometricvalidationofpatientreportedoutcomesrelevanttoindividualswithspinalmuscularatrophyandtheircaregivers
AT menciadelemus preliminarypsychometricvalidationofpatientreportedoutcomesrelevanttoindividualswithspinalmuscularatrophyandtheircaregivers
AT julitamedina preliminarypsychometricvalidationofpatientreportedoutcomesrelevanttoindividualswithspinalmuscularatrophyandtheircaregivers
AT mariadumont preliminarypsychometricvalidationofpatientreportedoutcomesrelevanttoindividualswithspinalmuscularatrophyandtheircaregivers
AT pablorebollo preliminarypsychometricvalidationofpatientreportedoutcomesrelevanttoindividualswithspinalmuscularatrophyandtheircaregivers
AT juanfranciscovazquezcosta preliminarypsychometricvalidationofpatientreportedoutcomesrelevanttoindividualswithspinalmuscularatrophyandtheircaregivers